From the Journal

The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention

Aris Karatasakis, MD1;  Rahel Iwnetu, MD1;  Barbara A. Danek, MD1;  Dimitri Karmpaliotis, MD2;  Khaldoon Alaswad, MD3;  Farouc A. Jaffer, MD, PhD4;  Robert W. Yeh, MD, MSc, MBA5;  David E. Kandzari, MD6; Nicholas J. Lembo, MD6;  Mitul Patel, MD7;  Ehtisham Mahmud, MD7;  William L. Lombardi, MD8;  R. Michael Wyman, MD9;  J. Aaron Grantham, MD10;  Anthony H. Doing, MD11;  Catalin Toma, MD12;  James W. Choi, MD13;  Barry F. Uretsky, MD14;  Jeffrey W. Moses, MD2;  Ajay J. Kirtane, MD2;  Ziad A. Ali, MD, DPhil2; Manish Parikh, MD2;  Judit Karacsonyi, MD1;  Bavana V. Rangan, BDS, MPH1;  Craig A. Thompson, MD15;  Subhash Banerjee, MD1;  Emmanouil S. Brilakis, MD, PhD1,16

Published online ahead of print on 2017 Jan 15

We sought to determine the effect of age and sex on procedural outcomes and efficiency of chronic total occlusion percutaneous coronary intervention....

Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction

Björn Redfors, MD, PhD1;  Tullio Palmerini, MD2;  Adriano Caixeta, MD, PhD3;  Girma Minalu Ayele, PhD1;  Dominic P. Francese, MPH1;  Roxana Mehran, MD1,4;  Emmanouil S. Brilakis, MD, PhD5,6;  Ajay J. Kirtane, MD, SM1,7;  Dimitri Karmpaliotis, MD, PhD7;  Gregg W. Stone, MD1,7;  Philippe Généreux, MD1,8,9

Published online ahead of print on 2017 Mar 15

This study evaluates the contribution of chronic total occlusion (CTO)-related SYNTAX score (SS) to the overall SS for patients with CTO and compares the traditional SS to a simplified variant....

The SYNTAX Score for Chronic Total Occlusions: Building a Better Mousetrap

Salman A. Arain, MD and H. Vernon Anderson, MD

Published online ahead of print on 2017 Mar 15

The authors offer their thoughts on the limitations of the SYNTAX score when treating chronic total occlusions....

Atherectomy in Peripheral Artery Disease: A Review

Tariq M. Bhat, MD;  Maxwell E. Afari, MD;  Lawrence A. Garcia, MD

The physiological force and shear stress from angioplasty and stenting have made peripheral arterial disease (PAD) treatment challenging. This article presents a review of the current literature for the atherectomy devices used in PAD. 

 

J INVASIVE CARDIOL 2017;29(4):135-144.

Key words:

 ...

Ahead of Print

Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Devraj Sukul, MD1;  Milan Seth, MS1;  Simon R. Dixon, MBChB2;  Akshay Khandelwal, MD3;  Thomas A. LaLonde, MD4;  Hitinder S. Gurm, MD1,5

Published online ahead of print on 2017 Apr 15

We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).

Clinical Decision-Making for the Hemodynamic “Gray Zone” (FFR 0.75-0.80) and Long-Term Outcomes

Shiv Kumar Agarwal, MD1;  Srikanth Kasula, MD1;  Mohan M. Edupuganti, MD1;  Sameer Raina, MD1;  FNU Shailesh, MD1;  Ahmed Almomani, MD1;  Jason J. Payne, MD1;  Naga V. Pothineni, MD1;  Barry F. Uretsky, MD1,2;  Abdul Hakeem, MD1,2

Published online ahead of print on 2017 Apr 15

Fractional flow reserve (FFR) value between 0.75 and 0.80 is considered the “gray zone” and outcomes data relative to treatment strategy (revascularization vs medical therapy alone [deferral]) are limited for this group. A total of 238 patients with gray-zone FFR were followed for the primary endpoint of major adverse cardiovascular event (MACE).

Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease

Aya J. Alame, BA1;  Aris Karatasakis, MD1;  Judit Karacsonyi, MD1;  Barbara A. Danek, MD1;  Paul Sorajja, MD2;  Mario Gössl, MD2;  Santiago Garcia, MD3;  Hani Jneid, MD4;  Nikolaos Kakouros, MD5;  Jose Roberto Martinez-Parachini, MD1;  Erica Resendes, MS1;  Pratik Kalsaria, MS1;  Michele Roesle, RN1;  Bavana V. Rangan, BDS, MPH1;  Subhash Banerjee, MD1;  Emmanouil S. Brilakis, MD, PhD1,2

Published online ahead of print on 2017 Apr 15

This study compares the ACC/AHA and ESC guidelines for the management of patients with valvular heart disease (VHD).

Topic Center

News Wire

International Andreas
Gruentzig Society

Back to top